Literature DB >> 16248816

Peptide nucleic acids (PNAs), a chemical overview.

Andrea Porcheddu1, Giampaolo Giacomelli.   

Abstract

Peptide nucleic acid (PNA) is a nucleic acid analogue and a fully synthetic DNA/RNA-recognising ligand with a neutral peptide-like backbone. In spite of the large change on the backbone structure, PNA molecules bind strongly to complementary DNA and RNA sequences. Originally conceived as ligand for the recognition of double stranded DNA, the unique physico-chemical properties of PNAs have led to the development of a variety of research and diagnostic assays. The extraordinary properties of PNA may advance routine clinical tests and environmental analyses that will utilise the PNA technology. PNAs may also have an impact on in situ hybridisation, cytogenetics and industrial microbiology. This paper presents some recent achievements on peptide nucleic acids and discusses, from the viewpoint of literature, what the potential is and what the limitations of such compounds are. This review, which is not intended to be exhaustive, is mostly aimed at the current progress in PNA chemistry, structure, and hybridisation, highlighting some applications too.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248816     DOI: 10.2174/092986705774370664

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  17 in total

1.  PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor.

Authors:  Andrew V Dix; Jennie L Conroy; Kara M George Rosenker; David R Sibley; Daniel H Appella
Journal:  ACS Med Chem Lett       Date:  2015-03-13       Impact factor: 4.345

2.  PPG peptide nucleic acids that promote DNA guanine quadruplexes.

Authors:  Ethan A Englund; Pankaj Gupta; Christopher M Micklitsch; Mykola I Onyshchenko; Evgenia Remeeva; Ronald D Neumann; Igor G Panyutin; Daniel H Appella
Journal:  Chembiochem       Date:  2014-07-08       Impact factor: 3.164

3.  Capacitive monitoring of morpholino-DNA surface hybridization: experimental and theoretical analysis.

Authors:  Napoleon Tercero; Kang Wang; Rastislav Levicky
Journal:  Langmuir       Date:  2010-09-07       Impact factor: 3.882

4.  Development of a peptide nucleic acid-based multiprobe real-time PCR method targeting the hsp65 gene for differentiation among Mycobacterium abscessus strains.

Authors:  Kijeong Kim; Byoung-Jun Kim; Tae Sun Shim; Seok-Hyun Hong; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

5.  Cationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery.

Authors:  Huafeng Fang; Ke Zhang; Gang Shen; Karen L Wooley; John-Stephen A Taylor
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

6.  Molecular imaging of insulin-like growth factor 1 receptor in cancer.

Authors:  Yin Zhang; Weibo Cai
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

7.  Detection of a rare oligo(A) repeat tract mutation (8As-->7As) in the sequence encoding the La/SS-B autoantigen.

Authors:  Imre Semsei; Shannon Maier; Jennifer Workman-Azbill; László Urbán; Kathy Moser; Margit Zeher; Michael Bachmann; A Darise Farris
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

8.  Phospholipid conjugate for intracellular delivery of peptide nucleic acids.

Authors:  Gang Shen; Huafeng Fang; Yinyin Song; Agata A Bielska; Zhenghui Wang; John-Stephen A Taylor
Journal:  Bioconjug Chem       Date:  2009-09       Impact factor: 4.774

9.  Evaluation of peptide nucleic acid probe-based real-time PCR for detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens.

Authors:  Young Jin Choi; Hwi Jun Kim; Hee Bong Shin; Hae Seon Nam; Sang Han Lee; Joon Soo Park; Kwi Sung Park; Kyoung Ah Baek
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

10.  Pseudo-complementary PNA actuators as reversible switches in dynamic DNA nanotechnology.

Authors:  Damian Ackermann; Michael Famulok
Journal:  Nucleic Acids Res       Date:  2013-02-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.